By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


Key Statistics

Ownership: Public

Web Site: Imprimis
Symbol: immy

Company News
Imprimis (immy)' Dropless Therapy Shows Significant Advantages In A Large Peer-Reviewed Study 10/25/2016 8:39:34 AM
Imprimis (immy) Announces Availability Of Lower-Cost Option For The Treatment Of Lead Poisoning 10/17/2016 10:15:52 AM
Imprimis (immy)' Formulations To Be Highlighted At Upcoming Annual Ophthalmology Meeting In Chicago 10/13/2016 9:32:50 AM
Imprimis (immy)s' CEO Mark L. Baum To Debate At The Oxford Union Debating Society 10/6/2016 9:24:50 AM
Imprimis (immy) Axes 8% of Staff, Shuts Down Texas Facility 9/26/2016 10:01:21 AM
Following Congressional Hearing Investigating Mylan (MYL) And Epi-Pen, Imprimis (immy) Founder And CEO Publishes Drug Pricing Monograph 9/22/2016 9:08:21 AM
Imprimis (immy) Launches Imprimis Cares Access Network (ICAN) To Assist In Patient Access To Imprimis Cares Compounded Formulations 9/6/2016 1:30:42 PM
Imprimis (immy) Announces Second Quarter 2016 Financial Results 8/16/2016 11:31:42 AM
Imprimis (immy) Strengthens Senior Leadership Team With Key Hires In Operations, Quality, Manufacturing And Client Relations 8/15/2016 9:58:53 AM
Imprimis (immy) Announces $2 Million Equipment Sale Leaseback Agreement With Essex Capital Corporation 8/11/2016 6:46:25 AM